Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Untranslated | 2 | 2017 | 101 | 0.930 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 357 | 0.760 |
Why?
|
| RNA, Long Noncoding | 4 | 2017 | 152 | 0.750 |
Why?
|
| Genetic Loci | 2 | 2017 | 107 | 0.550 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2017 | 27 | 0.540 |
Why?
|
| DNA, Complementary | 1 | 2017 | 164 | 0.530 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 43 | 0.500 |
Why?
|
| Embryonic Stem Cells | 1 | 2016 | 151 | 0.470 |
Why?
|
| Cell Proliferation | 2 | 2016 | 941 | 0.470 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2016 | 619 | 0.470 |
Why?
|
| RNA Interference | 3 | 2015 | 590 | 0.360 |
Why?
|
| Dendrites | 1 | 2009 | 56 | 0.320 |
Why?
|
| Nerve Tissue Proteins | 1 | 2009 | 418 | 0.270 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 858 | 0.270 |
Why?
|
| Gene Expression | 1 | 2009 | 809 | 0.260 |
Why?
|
| Neurons | 1 | 2009 | 863 | 0.220 |
Why?
|
| Hospital Mortality | 2 | 2024 | 842 | 0.200 |
Why?
|
| Epilepsy | 1 | 2023 | 105 | 0.200 |
Why?
|
| Cells, Cultured | 3 | 2016 | 2092 | 0.190 |
Why?
|
| Nuclear Proteins | 2 | 2015 | 750 | 0.150 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 263 | 0.140 |
Why?
|
| Cell Movement | 2 | 2009 | 428 | 0.130 |
Why?
|
| Gene Library | 1 | 2017 | 98 | 0.130 |
Why?
|
| Genes, Developmental | 1 | 2016 | 5 | 0.130 |
Why?
|
| DNA Primers | 1 | 2017 | 289 | 0.130 |
Why?
|
| Neurogenesis | 1 | 2016 | 60 | 0.120 |
Why?
|
| Magnetic Fields | 1 | 2015 | 3 | 0.120 |
Why?
|
| Cornea | 1 | 2015 | 17 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2015 | 1471 | 0.120 |
Why?
|
| DNA Modification Methylases | 1 | 2014 | 18 | 0.110 |
Why?
|
| Polycomb-Group Proteins | 1 | 2014 | 21 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2016 | 587 | 0.110 |
Why?
|
| Transcriptome | 1 | 2017 | 340 | 0.110 |
Why?
|
| Ataxia | 1 | 2013 | 21 | 0.110 |
Why?
|
| Tremor | 1 | 2013 | 23 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2015 | 155 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2015 | 173 | 0.110 |
Why?
|
| Fragile X Syndrome | 1 | 2013 | 27 | 0.100 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2013 | 38 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 841 | 0.100 |
Why?
|
| Humans | 10 | 2024 | 59389 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2012 | 83 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 194 | 0.100 |
Why?
|
| RNA Stability | 1 | 2012 | 97 | 0.100 |
Why?
|
| Rats, Wistar | 2 | 2009 | 179 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 305 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2014 | 271 | 0.100 |
Why?
|
| Nucleic Acid Conformation | 1 | 2012 | 234 | 0.090 |
Why?
|
| Argonaute Proteins | 1 | 2012 | 129 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2014 | 378 | 0.090 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2012 | 137 | 0.090 |
Why?
|
| Huntington Disease | 1 | 2012 | 146 | 0.090 |
Why?
|
| Histones | 1 | 2014 | 457 | 0.090 |
Why?
|
| Transfection | 2 | 2009 | 675 | 0.090 |
Why?
|
| Bromodeoxyuridine | 1 | 2009 | 40 | 0.080 |
Why?
|
| Inverted Repeat Sequences | 1 | 2009 | 14 | 0.080 |
Why?
|
| Electroporation | 1 | 2009 | 31 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2009 | 70 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 125 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2015 | 493 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 156 | 0.080 |
Why?
|
| Rats | 2 | 2009 | 1910 | 0.080 |
Why?
|
| Malformations of Cortical Development, Group II | 1 | 2008 | 1 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 589 | 0.070 |
Why?
|
| Dyslexia | 1 | 2008 | 8 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 354 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 254 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2024 | 2375 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 111 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2009 | 331 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2012 | 1466 | 0.070 |
Why?
|
| Animals | 4 | 2015 | 19650 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 248 | 0.060 |
Why?
|
| New York City | 1 | 2024 | 75 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 676 | 0.060 |
Why?
|
| Pregnancy | 1 | 2009 | 2213 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2024 | 6071 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 650 | 0.050 |
Why?
|
| Comorbidity | 1 | 2024 | 1078 | 0.040 |
Why?
|
| Hospitals | 1 | 2023 | 378 | 0.040 |
Why?
|
| Length of Stay | 1 | 2023 | 776 | 0.040 |
Why?
|
| Mice | 1 | 2012 | 10291 | 0.040 |
Why?
|
| Aged | 2 | 2024 | 13408 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2024 | 720 | 0.030 |
Why?
|
| Female | 2 | 2024 | 30726 | 0.030 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2015 | 23 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 258 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 178 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 5119 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 527 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 392 | 0.030 |
Why?
|
| 5' Untranslated Regions | 1 | 2013 | 24 | 0.030 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2013 | 32 | 0.030 |
Why?
|
| Heterozygote | 1 | 2013 | 161 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 384 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 474 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 1368 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1555 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 1033 | 0.020 |
Why?
|
| Pyramidal Cells | 1 | 2008 | 26 | 0.020 |
Why?
|
| Choristoma | 1 | 2008 | 22 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2008 | 78 | 0.020 |
Why?
|
| Adult | 1 | 2024 | 15681 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 16314 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2008 | 306 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1552 | 0.020 |
Why?
|
| Hippocampus | 1 | 2008 | 246 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 2456 | 0.020 |
Why?
|
| Male | 1 | 2024 | 27749 | 0.010 |
Why?
|